Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 2
1988 1
1990 1
1991 1
1992 1
1994 1
1995 2
1996 1
1997 3
1999 2
2000 1
2001 2
2002 3
2003 1
2004 2
2005 1
2006 2
2007 1
2008 2
2009 3
2010 1
2011 3
2012 3
2013 6
2014 3
2015 2
2016 3
2017 2
2019 2
2021 2
2022 4
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: elmazeg
Page 1
Showing results for elmazeg elgamil
Search for Elmazeg Elgamli instead (2 results)
Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers.
Parkhurst MR, Robbins PF, Tran E, Prickett TD, Gartner JJ, Jia L, Ivey G, Li YF, El-Gamil M, Lalani A, Crystal JS, Sachs A, Groh E, Ray S, Ngo LT, Kivitz S, Pasetto A, Yossef R, Lowery FJ, Goff SL, Lo W, Cafri G, Deniger DC, Malekzadeh P, Ahmadzadeh M, Wunderlich JR, Somerville RPT, Rosenberg SA. Parkhurst MR, et al. Cancer Discov. 2019 Aug;9(8):1022-1035. doi: 10.1158/2159-8290.CD-18-1494. Epub 2019 Jun 4. Cancer Discov. 2019. PMID: 31164343 Free PMC article.
Targeted cytokine production.
Segal DM, Qian JH, Titus JA, Moreno MB, George AJ, Jost CR, Kurucz I, el-Gamil M, Wunderlich JR. Segal DM, et al. Int J Cancer Suppl. 1992;7:36-8. Int J Cancer Suppl. 1992. PMID: 1428400 Review.
Frequent nuclear/cytoplasmic localization of beta-catenin without exon 3 mutations in malignant melanoma.
Rimm DL, Caca K, Hu G, Harrison FB, Fearon ER. Rimm DL, et al. Am J Pathol. 1999 Feb;154(2):325-9. doi: 10.1016/s0002-9440(10)65278-9. Am J Pathol. 1999. PMID: 10027390 Free PMC article.
Previously, 6 of 27 melanoma cell lines were found to have beta-catenin exon 3 mutations affecting the N-terminal phosphorylation sites (Rubinfeld B, Robbins P, Elgamil M, Albert I, Porfiri E, Polakis P: Stabilization of beta-catenin by genetic defects in melanoma cell lin …
Previously, 6 of 27 melanoma cell lines were found to have beta-catenin exon 3 mutations affecting the N-terminal phosphorylation sites (Rub …
64 results